EUVIMEDEUVIMED entdecken
Crossref

Clinical Factors That Influence Repeat 68 Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68 Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study

Pan Thin, Masatoshi Hotta, Andrei Gafita, Tristan Grogan, Johannes Czernin, Jeremie Calais, Ida Sonni

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Pan Thin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, C…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Gallium Radioisotopes, Positron Emission Tomography Computed Tomography, Gallium Isotopes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsGallium RadioisotopesPositron Emission Tomography Computed TomographyGallium IsotopesEdetic AcidOligopeptidesHumansMaleRetrospective StudiesAgedMiddle AgedRecurrenceNeoplasm Recurrence, LocalAged, 80 and overProstate-Specific Antigen

Stichwörter der Autor:innen

68Ga-PSMA-11 PET/CTPETPSA kineticsclinical observationgenitourinaryoncology

Substanzen

Gallium Radioisotopesgallium 68 PSMA-11Gallium IsotopesEdetic AcidOligopeptidesProstate-Specific Antigen

Autor:innen und Institutionen

  • Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California.
  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California.
  • Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California.
  • Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; jcalais@mednet.ucla.edu.
  • Department of Radiological Sciences, David Geffen School of Medicine, UCLA, Los Angeles, California; and.
  • Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy.

Zitieren

APA

Thin, P., Hotta, M., Gafita, A., Grogan, T., Czernin, J., Calais, J., & Sonni, I. (2024). Clinical Factors That Influence Repeat 68 Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68 Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267591

Vancouver

Thin P, Hotta M, Gafita A, Grogan T, Czernin J, Calais J, et al. Clinical Factors That Influence Repeat 68 Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68 Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267591

BibTeX
@article{Thin2024,
  author = {Thin, Pan and Hotta, Masatoshi and Gafita, Andrei and Grogan, Tristan and Czernin, Johannes and Calais, Jeremie and Sonni, Ida},
  title = {Clinical Factors That Influence Repeat 68 Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68 Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267591}
}
Kostenlos starten →